» Articles » PMID: 6121579

A Radioreceptor Assay to Study the Affinity of Benzodiazepines and Their Receptor Binding Activity in Human Plasma Including Their Active Metabolites

Overview
Specialty Pharmacology
Date 1982 Apr 1
PMID 6121579
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

1 A radioreceptor assay has been established to measure the receptor affinities of numerous benzodiazepines in clinical use. 2 The time course of receptor binding activity was studied by this method in the plasma of eight healthy subjects randomly treated with 1 mg lormetazepam (Noctamid, 2 mg flunitrazepam (Rohypnol, and 10 mg diazepam (Valium, and placebo on a cross-over basis. Blood samples were collected up to 154 h after treatment. 3 Receptor affinities of numerous benzodiazepines on vitro show good correlation with therapeutic human doses (r = 0.96) and may be predictive of drug potency in man. 4 Mean peak plasma levels of lormetazepam binding equivalents were 4.8 +/- 1 ng/ml at 2 h after lormetazepam, 7.2 +/- 1.8 ng/ml at 8 h after flunitrazepam, and 17.9 +/- 2.7 ng/ml at 15 h after diazepam. Plasma elimination half-lives of benzodiazepine binding equivalents were 9.3, 23 and 63 h, respectively. 5 Slow elimination of benzodiazepine binding equivalents following flunitrazepam and diazepam may be due to persistent active metabolites.

Citing Articles

The role of benzodiazepines in common conditions: a narrative review focusing on lormetazepam.

Pallanti S Int Clin Psychopharmacol. 2024; 39(3):139-147.

PMID: 38277240 PMC: 10965132. DOI: 10.1097/YIC.0000000000000529.


Dependence liability of lormetazepam: are all benzodiazepines equal? The case of the new i.v. lormetazepam for anesthetic procedures.

Horowski R J Neural Transm (Vienna). 2020; 127(8):1107-1115.

PMID: 32468272 PMC: 8823007. DOI: 10.1007/s00702-020-02209-8.


Classification of benzodiazepine hypnotics in humans based on receptor occupancy theory.

Ito K, Yamada Y, Nakamura K, Sawada Y, Iga T J Pharmacokinet Biopharm. 1993; 21(1):31-41.

PMID: 8410682 DOI: 10.1007/BF01061774.


Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerations.

Drayer D Drugs. 1982; 24(6):519-42.

PMID: 6759093 DOI: 10.2165/00003495-198224060-00003.


Assay of midazolam and brotizolam in plasma by a gas chromatographic and a radioreceptor technique.

Jochemsen R, van Rijn P, Hazelzet T, Breimer D Pharm Weekbl Sci. 1983; 5(6):308-12.

PMID: 6664823 DOI: 10.1007/BF02074860.


References
1.
Rieder J, RENTSCH G . [Metabolism and pharmacokinetics of the new psychoactive drug 7-Chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine (Ro 5-4556) in man]. Arzneimittelforschung. 1968; 18(12):1545-56. View

2.
Kaplan S, Jack M, Alexander K, Weinfeld R . Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations. J Pharm Sci. 1973; 62(11):1789-96. DOI: 10.1002/jps.2600621111. View

3.
Dasberg H, van der Kleijn E, Guelen J, van Praag H . Plasma concentrations of diazepam and of its metabolite N-desmethyldiazepam in relation to anxiolytic effect. Clin Pharmacol Ther. 1974; 15(5):473-83. DOI: 10.1002/cpt1974155473. View

4.
Dasberg H . Effects and plasma levels of N-desmethyldiazepam after oral administration in normal volunteers. Psychopharmacologia. 1975; 43(2):191-8. DOI: 10.1007/BF00421024. View

5.
Bond A, Hailey D, Lader M . Plasma concentrations of benzodiazepines. Br J Clin Pharmacol. 1977; 4(1):51-6. PMC: 1428979. DOI: 10.1111/j.1365-2125.1977.tb00666.x. View